Co-founder of 4DMT; served as Chief Scientific Advisor and director since inception in 2013 (per the S-1). Professor of Chemical and Biomolecular Engineering, Bioengineering, and Molecular and Cell Biology at U.C. Berkeley since 1999 and Director of the Berkeley Stem Cell Center since 2011; pioneered the application of directed evolution to the AAV capsid.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.